Saara Entrepreneur

Manufacturer	Rotateq
Composition	Rotavirus Vaccine
Treatment	Live Attenuated
Prescription/Non prescription	Prescription
Form	Injection
Packaging Type	Box

RotaTeq Rotavirus Vaccine Live Oral, Pentavalent is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by Types G1, G2, G3, G4, and G9 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. The first dose of RotaTeq should be administered between 6 and 12 weeks of age.

The vaccination series consists of 3 ready-to-use liquid doses of RotaTeq administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4- to 10-week intervals. The third dose should not be given after 32 weeks of age.

Packaging Size	2ml
Brand	Rotasill
Manufacturer	Other
Composition	Rotavirus Vaccine ()
Treatment	Live Attenuated
Prescription/Non prescription	Prescription
Form	Other

 

Rotasill-Liquid should be administered as a 3-dose regimen, 4 weeks apart, beginning at 6 weeks of age. The three dose regimen should be completed by one year of age. ROTASIIL-Liquid may be co-administered with other routine childhood immunizations (i.e., Diphtheria, Tetanus and Pertussis [DTwP], Hepatitis B vaccine, H. influenzae type b (Hib) vaccine, inactivated polio vaccine (IPV) and Oral Polio Vaccine [OPV]). Because of the typical age distribution of rotavirus gastroenteritis, rotavirus vaccination of children > 24 months of age is not recommended. Based on recommendations from the World Health Organization, if the routine childhood immunizations are initiated later than 6 weeks of age and/or at a longer dose interval than 4-weeks, RROTASIIL-Liquid can still be administered, by itself or concomitantly with DTwP. There are no restrictions on the infant's consumption of food or liquid, including breast milk, either before or after vaccination with ROTASIIL-Liquid.

It is recommended that infants who receive ROTASIIL-Liquid as the first dose should complete the three dose series with ROTASIIL-Liquid. There is no data on safety, immunogenicity or efficacy of ROTASIIL-Liquid when administered interchangeably with other available rotavirus vaccines.

In case that an incomplete dose is administered (the baby spits up or regurgitates most of the vaccine), a single replacement dose may be administered at the same vaccination visit*. The baby may continue to receive the remaining doses as per schedule.

*Physician's discretion is advised

Packaging Size	0.5ml
Brand	Rotasure Oral Vaccine
Manufacturer	Abbott
Composition	Rotavirus Vaccine (Live Attenuated, Oral)
Treatment	Prevention of diarrhea due to rotavirus
Prescription/Non prescription	Prescription

Product DescriptionRotasure Oral Vaccine is a medicine used in the prevention of diarrhea due to rotavirus.
It is usually given as a 3-dose oral regimen, 4 weeks apart, beginning at 6 weeks of age.

Packaging Size	0.5ml
Brand	Rotavac
Manufacturer	Bhart Biotech
Composition	Rotavirus Vaccine (Live Attenuated, Oral)
Prescription/Non prescription	Prescription
Form	Injection

Product Description

With the help of our expert team members, we have been able to provide Rotavirus Vaccine.

Other Details:

• Live Attenuated, Oral
• For oral administration only, not for injection